PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesis.
Mol Cell. 2021 Nov 4;81(21):4509-4526.e10. doi: 10.1016/j.molcel.2021.08.039. Epub 2021 Sep 23.
Mol Cell. 2021.
PMID: 34560002